Tong Ren Tang Technologies Receives Cambodian Regulatory Approval for Angong Niuhuang Wan Traditional Medicine
Reuters
Sep 26
<a href="https://laohu8.com/S/TGRNF">Tong Ren Tang Technologies</a> Receives Cambodian Regulatory Approval for Angong Niuhuang Wan Traditional Medicine
**Tong Ren Tang Technologies Co. Ltd. Receives Regulatory Approval for Traditional Medicine in Cambodia** Tong Ren Tang Technologies Co. Ltd. announced that its subsidiary, Beijing Tong Ren Tang Chinese Medicine Company Limited, has received a traditional medicine registration license from the Department of Drugs and Food of the Ministry of Health of Cambodia. The license allows the company's product, "Tong Ren Tang Angong Niuhuang Wan," to be sold in the Cambodian market. This regulatory approval is expected to help the company expand its distribution channels and market presence in Cambodia. The company noted that the approval will not have a material impact on its current operations or performance, and sales may be affected by local policy changes, exchange rates, and market competition. No other organizations were mentioned as recipients of this regulatory approval.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Tong Ren Tang Technologies Co. Ltd. published the original content used to generate this news brief on September 26, 2025, and is solely responsible for the information contained therein.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.